From SNPedia
The accuracy of claims about this snp are called into question by table 1 of 10.1371/journal.pbio.1000294
[PMID 18477659] rs7754840 replicated as significant for type-2 diabetes risk in 1,900 Japanese patients, with odds ratio of 1.28 (CI: 1.17-1.41, p = 4.5 x 10e-7)
[PMID 18285412] type-2 diabetes Carriers of the (C;G) and (C;C) genotypes of rs7754840 had 11% and 24% lower first-phase insulin release in an IVGTT compared to that in carriers of the (G;G) genotype (P=0.002). The C allele was also associated with higher glucose area under the curve in an OGTT (P=0.016).
[PMID 18516622] rs7754840 type-2 diabetes Ashkenazi Jewish population shows an even stronger effect for rs7754840 than the general Caucasian population, based on 1,131 cases versus 1,147 controls.
[PMID 19033397] This SNP was confirmed to be associated with type-2 diabetes in a study of 500+ Japanese patients plus pooled meta-analysis with 6 previous association studies (also of Japanese).
| ? | (C;C) (C;G) (G;G) |
 |
[PMID 19258437] A Genetic Variant in the IGF2BP2 Gene may Interact with Fetal Malnutrition on Glucose Metabolism.
| GWAS snp
|
| PMID
| [PMID 17463246]
|
| Trait
| Type 2 diabetes
|
| Title
| Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
|
| Risk Allele
| C
|
| P-val
| 3.9999999999999998E-11
|
| Odds Ratio
| 1.12 [1.08-1.16]
|
Related to CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1-LIKE 1; CDKAL1
according to
omim 611259. See
also
| PharmGKB | PA162168096 |
| Name | |
| Annotation | rs7754840 demonstrated association with Type 2 Diabetes in a GWAS of Finnish and Swedish patients and controls. |
| Gene | CDKAL1 |
| Featue | |
| Evidence | PubMed ID:17463246 |
| Drugs | |
| Diseases | Diabetes Mellitus, Type 2 |
| Curation Level | Curated |